Credit Suisse analyst Judah Frommer maintains Akili (NASDAQ:AKLI) with a Outperform and raises the price target from $4 to $4.5.
Crude Oil Rises Over 1%; Cidara Therapeutics Shares Spike Higher
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 1% on Wednesday.
The Dow traded down 0.57% to 34,443.02 while the NASDAQ fell 1.19% to 13,853.60. The S&P 500, also fell, dropping, 0.80% to 4,460.96.
